FDA Approves Cyclobenzaprine For Fibromyalgia in Adults
August 15, 2025
The first new FDA-approved therapy for the treatment of fibromyalgi...
Read More
Increased Prescribing of ADHD Medication and Real-World Outcomes Over Time
August 8, 2025
A study recently published investigated whether the real-world bene...
Read More
Oldest-Old Respond Better to ECT Than Younger Adults, Study Finds
August 5, 2025
Electroconvulsive therapy may be a highly effective and safe treatm...
Read More
Antidepressant Discontinuation Symptoms
July 28, 2025
Understanding the true incidence and severity of antidepressant dis...
Read More
Esketamine Monotherapy in Adults With Treatment-Resistant Depression
July 24, 2025
A new phase 4 randomized controlled trial evaluated the efficacy of...
Read More
The Relevance of Insomnia Among Healthcare Workers
July 22, 2025
A recent study assessed the prevalence and contributing factors of ...
Read More
20-Year Study of PTSD in World Trade Center Responders
July 19, 2025
There are many studies that examine the impact of post-traumatic st...
Read More
Paternal Perinatal Depression, Anxiety, and Stress and Child Development
July 14, 2025
While maternal perinatal mental health has long been a focus of res...
Read More
Early Post-Stroke Counseling Tied to Lower Rates of Anxiety and Depression
July 12, 2025
A new study offers robust real-world evidence supporting the effect...
Read More
Lithium Versus Quetiapine Augmentation For Treatment-Resistant Depression
July 8, 2025
A major randomized controlled trial compared the long-term clinical...
Read More
New Study Links Psychiatric Medications to Increased Risk of Amyotrophic Lateral Sclerosis
July 6, 2025
A recent study reveals a notable association between the use of com...
Read More
Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings
July 3, 2025
A comprehensive systematic review reexamines the long-term conseque...
Read More